SEC Form 4 · accession 0001140361-15-012691
REPLIGEN CORP · RGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Howard Benjamin
Other
Period of report
Mar 19, 2015
Accepted (ET)
Mar 19, 2015 · 5:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000730272
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Mar 18, 2015 | M | 10,000 | $6.23 | A | 58,542 | D | |
| Common stock | Mar 18, 2015 | M | 3,807 | $15.91 | A | 62,349 | D | |
| Common stockF1 | Mar 18, 2015 | S | 15,795 | $32.6333 | D | 46,554 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| StockOption (Right to Buy) | $6.23 | Mar 18, 2015 | M | 10,000 | D | Feb 28, 2015 | Feb 28, 2023 | Common Stock | 10,000 | 20,000 | D |
| Stock Option (Right to Buy)F2 | $15.91 | Mar 18, 2015 | M | 3,807 | D | — | Feb 27, 2024 | Common Stock | 3,807 | 7,614 | D |
Explanation of responses
- F11. This transaction was executed in multiple trades at prices ranging from $32.55 to $32.728. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F22. 3,807 shares vest and become exercisable on each of the following dates: 2/27/2015, 2/27/2016 and 2/27/2017.